Preview

Российский кардиологический журнал

Расширенный поиск

ПАРОКСИЗМАЛЬНЫЕ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ (Ч. II)

Полный текст:

Об авторе

Б. А. Татарский
Федеральный центр сердца, крови и эндокринологии им. В. А. Алмазова , Санкт-Петербург
Россия


Список литературы

1. Galve E., Rius T., Ballester R., et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am. Coll. Cardiol. 1996;27: 1079 -82.

2. Peuhkurinen K., Niemela M., Ylitalo A., et al. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. Am. J. Cardiol. 2000;85:462-5.

3. Li H., Natale A., Tomassoni G., et al. Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. Am. J. Cardiol.1999;84:1096-1098.

4. Greenbaum R.A., Campbell T.J., Channer K.S., et al. Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD study (European and Australian Multicenter Evaluative Research on atrial fibrillation Dofetilide) Study. Circulation 1998;98:1633-1639.

5. Singh S., Zoble R.G., Yellen L., et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000;102: 2385-2390.

6. Prystowsky E., Benson D., Fuster V., et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the ubcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 1996;93:1262-1277.

7. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415:219 -26.

8. Pelargonio G., Prystowsky E. Rate versus rhythm control in the management of patients with atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med. 2005;2:514-521.

9. Wyse D., Waldo A., DiMarco J., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 2002;347:1825-1833.

10. Kerr C.R., Humphries K.H., Talajic M., et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am. Heart. J. 2005;149: 489 -496.

11. Vardas P.E., Kochiadakis G.E., Igoumenidis N.E., et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. Chest 2000;117: 1538 -45.

12. Naccarelli G.V., Dell'Orfano J.T., Wolbrette D.L., et al. Management of atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion. Am. J. Cardiol. 2000;85: 36D-45D.

13. Prystowsky E.N. Management of atrial fibrillation: therapeutic options and clinical decisions. Am. J. Cardiol.2000;85: 3-11.

14. UK Propafenone PSVT Study Group. A randomized, placebocontrolled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 1995;92:2550-2557.

15. Lenzi T., Boriani G., Botto G., et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69 -72.

16. Reisinger J., Gatterer E., Lang W., et al. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur. Heart J. 2004;25:1318-1324

17. Camm J., Haffajee C., Sheldon R., et al. International Consensus Roundtable on Atrial Fibrillation. Cardiol Rev 2000;17 (Suppl.) 1-19.

18. Bianconi L., Mennuni M., Lukic V., et al. Effects of oral propafenone administration before electrical cardioversion of atrial fibrillation: a placebo-controlled study. J. Am. Coll. Cardiol. 1996;28: 700-706.

19. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415:219-26.

20. Maisel W.H., Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am. J. Cardiol. 2003; 91: 2D-8D.

21. Hohnloser S., Kuch K., Lilienthal J. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF) -a randomised trial. Lancet 2000;356: 1789-1794.

22. Carlsson J., Miketic S., Windeler J., et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J. Am. Coll. Cardiol. 2003; 41: 1690-1996.

23. Khan I.A., Mehta N.J., Gowda R.M. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int. J. Cardiol. 2003;89:239-248.


Рецензия

Для цитирования:


Татарский Б.А. ПАРОКСИЗМАЛЬНЫЕ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ (Ч. II). Российский кардиологический журнал. 2008;(3):55-64.

For citation:


Tatarsky B.A. Paroxysmal atrial fibrillation (part II). Russian Journal of Cardiology. 2008;(3):55-64. (In Russ.)

Просмотров: 82


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)